04Mar
Global Private Equity Newsletter - Winter 2020 Edition: Deals in the Life Sciences Sector Article 1: Value Drivers and Risks
As the private equity industry matures, and the deal landscape becomes more competitive, private equity sponsors are becoming more prepared and capable of investing in sectors previously considered overly-regulated, requiring advanced chemistry or...
By:
Dechert LLP
Related
The recent judicial review in R (Holborn Studios) v London Borough of Hackney raises important consi...
Read More >
On December 16, 2019, the National Labor Relations Board (the “Board”) issued a new decision that ...
Read More >
The IRS recently issued guidance on the tax treatment, withholding and reporting for required distri...
Read More >
New measures, announced on 21 June 2020, will allow the UK Government to intervene in relation to tr...
Read More >
The state of Washington has weighed in on the debate as to whether obesity is a disability under dis...
Read More >
Governor Charlie Baker announced today that all construction projects in Massachusetts may reopen im...
Read More >